Yilmaz Y - Search Results

1

Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease.

Alkayyali T, Qutranji L, Kaya E, Bakir A, Yilmaz Y. Alkayyali T, et al. Among authors: yilmaz y. Acta Diabetol. 2020 May;57(5):613-618. doi: 10.1007/s00592-019-01467-7. Epub 2020 Jan 2. Acta Diabetol. 2020. PMID: 31897769

2

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.

Yilmaz Y, Ulukaya E, Atug O, Dolar E. Yilmaz Y, et al. Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1247-51. doi: 10.1097/MEG.0b013e32832b77ae. Eur J Gastroenterol Hepatol. 2009. PMID: 19474742

3

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, Ozdogan O, Duman D, Imeryuz N, Avsar E, Kalayci C. Yilmaz Y, et al. Metabolism. 2010 Sep;59(9):1327-30. doi: 10.1016/j.metabol.2009.12.012. Epub 2010 Jan 22. Metabolism. 2010. PMID: 20096896

4

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, Oflaz H, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Yilmaz Y, et al. Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7. Atherosclerosis. 2010. PMID: 20181335

5

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.

Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Aktas B, et al. Among authors: yilmaz y. Metabolism. 2011 Apr;60(4):544-9. doi: 10.1016/j.metabol.2010.05.008. Epub 2010 Jun 26. Metabolism. 2011. PMID: 20580037

6

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

Yilmaz Y, Eren F, Yonal O, Kurt R, Aktas B, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Yilmaz Y, et al. Eur J Clin Invest. 2010 Oct;40(10):887-92. doi: 10.1111/j.1365-2362.2010.02338.x. Epub 2010 Aug 19. Eur J Clin Invest. 2010. PMID: 20624171

7

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.

Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E. Yilmaz Y, et al. Scand J Gastroenterol. 2011 Jan;46(1):91-7. doi: 10.3109/00365521.2010.516452. Epub 2010 Sep 1. Scand J Gastroenterol. 2011. PMID: 20809771

8

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis.

Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA, Korkmaz S, Ulukaya E, Ozdogan O, Imeryuz N, Avsar E, Kalayci C. Yilmaz Y, et al. Ann Clin Biochem. 2010 Nov;47(Pt 6):549-53. doi: 10.1258/acb.2010.010169. Epub 2010 Oct 6. Ann Clin Biochem. 2010. PMID: 20926473

9

Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease.

Yilmaz Y, Yonal O, Eren F, Kurt R, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Yilmaz Y, et al. Clin Chem Lab Med. 2011 Jan;49(1):93-7. doi: 10.1515/CCLM.2011.022. Epub 2010 Nov 16. Clin Chem Lab Med. 2011. PMID: 21077793

10

Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis.

Yilmaz Y, Ulukaya E. Yilmaz Y, et al. Curr Med Chem. 2011;18(5):725-32. doi: 10.2174/092986711794480122. Curr Med Chem. 2011. PMID: 21182485 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

956 results

Search Page

Filters